KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Repurchased
Ratios

Clover Health Investments (CLOV) Amortization - Deferred Charges (2020 - 2022)

Clover Health Investments (CLOV) has disclosed Amortization - Deferred Charges for 3 consecutive years, with $3000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Amortization - Deferred Charges changed N/A year-over-year to $3000.0, compared with a TTM value of $30000.0 through Dec 2022, changed N/A, and an annual FY2022 reading of $30000.0, down 99.78% over the prior year.
  • Amortization - Deferred Charges was $3000.0 for Q4 2022 at Clover Health Investments, down from $9000.0 in the prior quarter.
  • Across five years, Amortization - Deferred Charges topped out at $13.7 million in Q1 2021 and bottomed at $3000.0 in Q4 2022.
  • Average Amortization - Deferred Charges over 3 years is $3.0 million, with a median of $20000.0 recorded in 2021.
  • The sharpest move saw Amortization - Deferred Charges plummeted 99.5% in 2021, then plummeted 59.09% in 2022.
  • Year by year, Amortization - Deferred Charges stood at $4.4 million in 2020, then tumbled by 99.5% to $22000.0 in 2021, then plummeted by 86.36% to $3000.0 in 2022.
  • Business Quant data shows Amortization - Deferred Charges for CLOV at $3000.0 in Q4 2022, $9000.0 in Q3 2022, and $18000.0 in Q2 2022.